Bupropión

Bupropion is an atypical antidepressant belonging to the substituted cathinone and phenethylamine classes. First marketed under the brand name Wellbutrin, it functions as a norepinephrine-dopamine reuptake inhibitor (NDRI) and is prescribed for major depressive disorder, seasonal affective disorder, and smoking cessation. Unlike typical antidepressants, bupropion is less associated with sexual dysfunction and weight gain. It carries an elevated seizure risk, particularly in predisposed individuals, and should not be combined with other drugs without caution.

Also known as: Buproprion, Zyban, Wellbutrin, Amfebutamone, Wellbutrin xl

Classification

Chemical: Cathinone
Chemical: Medicine
Chemical: Phenethylamine
Psychoactive: Depressant
Psychoactive: Nootropic
Psychoactive: Stimulant
Tag: Antidepressant
Tag: Habit-Forming
Tag: Pharmaceutical

Effects

Excessive Sweating
Increased Heart Rate
Increased Blood Pressure
Ataxia
Seizure
Sedation
Euphoria
Mood Lift
Anxiety
Irritability
Paranoia
Focus Enhancement
Appetite Suppression
Auditory Hallucination
External Hallucination
Light Sensitivity
Dulled Perception
Sexual Dysfunction

Routes of Administration

Oral

Dosage

No data available for this section yet.

Duration

Onset: 0.25-1.5 h
After Effects: 1-6 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu